Position in ROIV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,821
-$106,580 QoQ
Shares Held
221
-94.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#418
of 494 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quent Capital, LLC holds $1,397,990 across 37 Biotechnology names. ROIV ranks #21 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
462 | $229,489 | |
| 2 | IMMX |
Immix Biopharma, Inc.
|
20,000 | $206,200 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
312 | $194,544 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
30,000 | $187,200 | |
| 5 | SLS |
SELLAS Life Sciences Group, Inc.
|
7,022 | $103,644 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
308 | $74,218 | |
| 7 | INCY |
Incyte Corp
|
429 | $48,631 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
337 | $41,309 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,821 | 221 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $114,401 | 4,130 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,213 | 102 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,543 | 102 | Shares | Sole | 2025-10-27 | |
| 2025-03-31 | $1,029 | 102 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $1,443 | 122 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,308 | 200 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $2,114 | 200 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $1,665 | 158 | Shares | Sole | 2024-06-28 | |
| 2023-12-31 | $22 | 2 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||